loadpatents
name:-0.088490009307861
name:-0.30019092559814
name:-0.029980897903442
Deshpande; Milind Patent Filings

Deshpande; Milind

Patent Applications and Registrations

Patent applications and USPTO patent grants for Deshpande; Milind.The latest application filed is for "aryl, heteroaryl, and heterocyclic compounds for treatment of medical disorders".

Company Profile
28.74.91
  • Deshpande; Milind - Madison CT
  • Deshpande; Milind - Coralville IA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Pharmaceutical compounds for treatment of medical disorders
Grant 11,447,465 - Wiles , et al. September 20, 2
2022-09-20
Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disorders
Grant 11,407,738 - Wiles , et al. August 9, 2
2022-08-09
Aryl, Heteroaryl, And Heterocyclic Compounds For Treatment Of Medical Disorders
App 20210269458 - WILES; Jason Allan ;   et al.
2021-09-02
Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disorders
Grant 11,084,800 - Wiles , et al. August 10, 2
2021-08-10
Disubstituted compounds for treatment of medical disorders
Grant 11,001,600 - Wiles , et al. May 11, 2
2021-05-11
Amino Compounds For Treatment Of Immune And Inflammatory Disorders
App 20210122733 - WILES; Jason Allan ;   et al.
2021-04-29
Amide Compounds For Treatment Of Immune And Inflammatory Disorders
App 20210115034 - Wiles; Jason Allan ;   et al.
2021-04-22
Amide compounds for treatment of immune and inflammatory disorders
Grant 10,919,884 - Wiles , et al. February 16, 2
2021-02-16
Amino compounds for treatment of immune and inflammatory disorders
Grant 10,906,887 - Wiles , et al. February 2, 2
2021-02-02
Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disorders
Grant 10,822,352 - Wiles , et al. November 3, 2
2020-11-03
Compounds for treatment of immune inflammatory disorders
Grant 10,807,952 - Wiles , et al. October 20, 2
2020-10-20
Aryl, Heteroaryl, And Heterocyclic Compounds For Treatment Of Immune And Inflammatory Disorders
App 20200262818 - Wiles; Jason Allan ;   et al.
2020-08-20
Amino compounds for treatment of complement mediated disorders
Grant 10,689,409 - Gadhachanda , et al.
2020-06-23
Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disorders
Grant 10,662,175 - Wiles , et al.
2020-05-26
Amino compounds for treatment of medical disorders
Grant 10,660,876 - Wiles , et al.
2020-05-26
Aryi, Heteroaryl, and Heterocyclic Pharmaceutical Compounds for Treatment of Medical Disorders
App 20200071301 - Wiles; Jason Allan ;   et al.
2020-03-05
Aryl, Heteroaryl, And Heterocyclic Compounds For Treatment Of Complement Mediated Disorders
App 20200062790 - Wiles; Jason Allan ;   et al.
2020-02-27
Ether compounds for treatment of complement mediated disorders
Grant 10,550,140 - Wiles , et al. Fe
2020-02-04
Pharmaceutical Compounds For Treatment Of Medical Disorders
App 20190382376 - Wiles; Jason Allan ;   et al.
2019-12-19
Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders
Grant 10,464,956 - Wiles , et al. No
2019-11-05
Amide compounds for treatment of complement mediated disorders
Grant 10,428,094 - Wiles , et al. October 1, 2
2019-10-01
Compounds for treatment of complement mediated disorders
Grant 10,428,095 - Wiles , et al. October 1, 2
2019-10-01
Ether compounds for treatment of medical disorders
Grant 10,385,097 - Wiles , et al. A
2019-08-20
Carbamate, ester, and ketone compounds for treatment of complement mediated disorders
Grant 10,370,394 - Wiles , et al.
2019-08-06
Aryl, Heteroaryl, And Heterocyclic Compounds For Treatment Of Medical Disorders
App 20190211033 - Wiles; Jason Allan ;   et al.
2019-07-11
Aryl, Heteroaryl, And Heterocyclic Compounds For Treatment Of Complement Mediated Disorders
App 20190185498 - Wiles; Jason Allan ;   et al.
2019-06-20
Phosphonate compounds for treatment of complement mediated disorders
Grant 10,301,336 - Wiles , et al.
2019-05-28
Amino Compounds For Treatment Of Complement Mediated Disorders
App 20190144473 - Gadhachanda; Venkat Rao ;   et al.
2019-05-16
Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disorders
Grant 10,287,301 - Wiles , et al.
2019-05-14
Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders
Grant 10,253,053 - Wiles , et al.
2019-04-09
Phosphonate Compounds For Treatment Of Complement Mediated Disorders
App 20190085005 - Wiles; Jason Allan ;   et al.
2019-03-21
Ether Compounds For Treatment Of Complement Mediated Disorders
App 20190048033 - Wiles; Jason Allan ;   et al.
2019-02-14
Compounds For Treatment Of Complement Mediated Disorders
App 20190031692 - Wiles; Jason Allan ;   et al.
2019-01-31
Amino compounds for treatment of complement mediated disorders
Grant 10,189,869 - Gadhachanda , et al. Ja
2019-01-29
Aryl, Heteroaryl, And Heterocyclic Compounds For Treatment Of Complement Mediated Disorders
App 20190023729 - Wiles; Jason Allan ;   et al.
2019-01-24
Amide compounds for treatment of medical disorders
Grant 10,138,225 - Wiles , et al. Nov
2018-11-27
Aryl, Heteroaryl, And Heterocyclic Compounds For Treatment Of Medical Disorders
App 20180305375 - Wiles; Jason Allan ;   et al.
2018-10-25
Subsituted Aliphanes, Cyclophanes, Heteraphanes, Heterophanes, Hetero-heteraphanes And Metallocenes Useful For Treating Hcv Infections
App 20180303800 - Wiles; Jason Allan ;   et al.
2018-10-25
Ether compounds for treatment of complement mediated disorders
Grant 10,106,563 - Wiles , et al. October 23, 2
2018-10-23
Alkyne Compounds for Treatment of Complement Mediated Disorders
App 20180298043 - Wiles; Jason Allan ;   et al.
2018-10-18
Phosphonate compounds for treatment of complement mediated disorders
Grant 10,100,072 - Wiles , et al. October 16, 2
2018-10-16
Alkyne Compounds For Treatment Of Complement Mediated Disorders
App 20180291047 - Wiles; Jason Allan ;   et al.
2018-10-11
Alkyne Compounds For Treatment Of Complement Mediated Disorders
App 20180291046 - Wiles; Jason Allan ;   et al.
2018-10-11
Compounds for the treatment of medical disorders
Grant 10,092,584 - Wiles , et al. October 9, 2
2018-10-09
Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero- heteraphanes and metallocenes useful for treating HCV infections
Grant 10,092,547 - Wiles , et al. October 9, 2
2018-10-09
Compounds for treatment of complement mediated disorders
Grant 10,087,203 - Wiles , et al. October 2, 2
2018-10-02
Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders
Grant 10,081,645 - Wiles , et al. September 25, 2
2018-09-25
Compounds For Treatment Of Immune Inflammatory Disorders
App 20180201580 - Wiles; Jason Allan ;   et al.
2018-07-19
Amide Compounds For Treatment Of Immune And Inflammatory Disorders
App 20180186782 - Wiles; Jason Allan ;   et al.
2018-07-05
Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disorders
Grant 10,011,612 - Wiles , et al. July 3, 2
2018-07-03
Amino Compounds For Treatment Of Immune And Inflammatory Disorders
App 20180179185 - Wiles; Jason Allan ;   et al.
2018-06-28
Disubstituted Compounds For Treatment Of Medical Disorders
App 20180179236 - Wiles; Jason Allan ;   et al.
2018-06-28
Amino Compounds For Treatment Of Medical Disorders
App 20180177761 - Wiles; Jason Allan ;   et al.
2018-06-28
Aryl, Heteroaryl, And Heterocyclic Compounds For Treatment Of Immune And Inflammatory Disorders
App 20180179186 - Wiles; Jason Allan ;   et al.
2018-06-28
Amide compounds for treatment of complement mediated disorders
Grant 10,005,802 - Wiles , et al. June 26, 2
2018-06-26
Phosphonate compounds for treatment of medical disorders
Grant 10,000,516 - Wiles , et al. June 19, 2
2018-06-19
Alkyne Compounds For Treatment Of Complement Mediated Disorders
App 20180072762 - Wiles; Jason Allan ;   et al.
2018-03-15
Substituted Aliphanes, Cyclophanes, Heteraphanes, Heterophanes, Hetero-heteraphanes And Metallocenes Useful For Treating Hcv Infections
App 20180055824 - Wiles; Jason Allan ;   et al.
2018-03-01
Aryl, Heteroaryl, And Heterocyclic Compounds For Treatment Of Complement Mediated Disorders
App 20180030075 - Wiles; Jason Allan ;   et al.
2018-02-01
Ether Compounds For Treatment Of Complement Mediated Disorders
App 20180022766 - Wiles; Jason Allan ;   et al.
2018-01-25
Compounds for Treatment of Complement Mediated Disorders
App 20180022767 - Wiles; Jason Allan ;   et al.
2018-01-25
Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections
Grant 9,833,440 - Wiles , et al. December 5, 2
2017-12-05
Alkyne compounds for treatment of complement mediated disorders
Grant 9,828,396 - Wiles , et al. November 28, 2
2017-11-28
Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders
Grant 9,796,741 - Gadhachanda , et al. October 24, 2
2017-10-24
Carbamate, Ester, And Ketone Compounds For Treatment Of Complement Mediated Disorders
App 20170298085 - Wiles; Jason Allan ;   et al.
2017-10-19
Amide Compounds For Treatment Of Complement Mediated Disorders
App 20170298084 - Wiles; Jason Allan ;   et al.
2017-10-19
Phosphonate Compounds For Treatment Of Complement Mediated Disorders
App 20170260219 - Wiles; Jason Allan ;   et al.
2017-09-14
Compounds for treatment of complement mediated disorders
Grant 9,758,537 - Wiles , et al. September 12, 2
2017-09-12
Carbamate, ester, and ketone compounds for treatment of complement mediated disorders
Grant 9,732,103 - Wiles , et al. August 15, 2
2017-08-15
Ether compounds for treatment of complement mediated disorders
Grant 9,732,104 - Gadhachanda , et al. August 15, 2
2017-08-15
Factor D Inhibitors Useful for Treating Inflammatory Disorders
App 20170226142 - Wiles; Jason Allan ;   et al.
2017-08-10
Amino Compounds for Treatment of Complement Mediated Disorders
App 20170189410 - Gadhachanda; Venkat Rao ;   et al.
2017-07-06
Amide compounds for treatment of complement mediated disorders
Grant 9,695,205 - Wiles , et al. July 4, 2
2017-07-04
Substituted Aliphanes, Cyclophanes, Heteraphanes, Heterophanes, Hetero-heteraphanes And Metallocenes Useful For Treating Hcv Infections
App 20170157096 - Wiles; Jason Allan ;   et al.
2017-06-08
Phosphonate compounds for treatment of complement mediated disorders
Grant 9,663,543 - Wiles , et al. May 30, 2
2017-05-30
Propolis-metal nanoparticle composition and methods of use
Grant 9,662,356 - DuBourdieu , et al. May 30, 2
2017-05-30
Factor D inhibitors useful for treating inflammatory disorders
Grant 9,643,986 - Wiles , et al. May 9, 2
2017-05-09
Amino compounds for treatment of complement mediated disorders
Grant 9,598,446 - Gadhachanda , et al. March 21, 2
2017-03-21
Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections
Grant 9,592,222 - Wiles , et al. March 14, 2
2017-03-14
Aryl, Heteroaryl, and Heterocyclic Compounds for Treatment of Medical Disorders
App 20170066783 - Wiles; Jason Allan ;   et al.
2017-03-09
Phosphonate Compounds for Treatment of Medical Disorders
App 20170057983 - Wiles; Jason Allan ;   et al.
2017-03-02
Amide Compounds for Treatment of Medical Disorders
App 20170057950 - Wiles; Jason Allan ;   et al.
2017-03-02
Ether Compounds for Treatment of Medical Disorders
App 20170057993 - Wiles; Jason Allan ;   et al.
2017-03-02
Compounds for the Treatment of Medical Disorders
App 20170056428 - Wiles; Jason Allan ;   et al.
2017-03-02
Substituted Aliphanes, Cyclophanes, Heteraphanes, Heterophanes, Hetero-heteraphanes And Metallocenes Useful For Treating Hcv Infections
App 20170007579 - Wiles; Jason Allan ;   et al.
2017-01-12
Amide Compounds For Treatment Of Complement Mediated Disorders
App 20160362398 - Wiles; Jason Allan ;   et al.
2016-12-15
Ether Compounds For Treatment Of Complement Mediated Disorders
App 20160362433 - Wiles; Jason Allan ;   et al.
2016-12-15
Aryl, Heteroaryl, And Heterocyclic Compounds For Treatment Of Complement Mediated Disorders
App 20160362399 - Wiles; Jason Allan ;   et al.
2016-12-15
Phosphonate Compounds For Treatment Of Complement Mediated Disorders
App 20160362432 - Wiles; Jason Allan ;   et al.
2016-12-15
Compounds For Treatment Of Complement Mediated Disorders
App 20160361329 - Wiles; Jason Allan ;   et al.
2016-12-15
Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections
Grant 9,474,742 - Wiles , et al. October 25, 2
2016-10-25
Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections
Grant 9,468,629 - Wiles , et al. October 18, 2
2016-10-18
Highly active nucleoside derivative for the treatment of HCV
Grant 9,447,132 - Deshpande , et al. September 20, 2
2016-09-20
Substituted Aliphanes, Cyclophanes, Heteraphanes, Heterophanes, Hetero-heteraphanes And Metallocenes Useful For Treating Hcv Infections
App 20160113907 - Wiles; Jason Allan ;   et al.
2016-04-28
Substituted Aliphanes, Cyclophanes, Heteraphanes, Heterophanes, Hetero-heteraphanes And Metallocenes Useful For Treating Hcv Infections
App 20160115157 - Wiles; Jason Allan ;   et al.
2016-04-28
Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections
Grant 9,273,082 - Wiles , et al. March 1, 2
2016-03-01
Stabilized Nucleotides For Medical Treatment
App 20160016986 - Deshpande; Milind ;   et al.
2016-01-21
Biphenyl imidazoles and related compounds useful for treating HCV infections
Grant 9,125,904 - Wiles , et al. September 8, 2
2015-09-08
Factor D Inhibitors Useful for Treating Inflammatory Disorders
App 20150239837 - Wiles; Jason Allan ;   et al.
2015-08-27
Aryl, Heteroaryl, and Heterocyclic Compounds for Treatment of Complement Mediated Disorders
App 20150239895 - Gadhachanda; Venkat Rao ;   et al.
2015-08-27
Alkyne Compounds for Treatment of Complement Mediated Disorders
App 20150239868 - Pais; Godwin ;   et al.
2015-08-27
Amino Compounds for Treatment of Complement Mediated Disorders
App 20150239894 - Gadhachanda; Venkat Rao ;   et al.
2015-08-27
Phosphonate Compounds for Treatment of Complement Mediated Disorders
App 20150239921 - Wiles; Jason Allan ;   et al.
2015-08-27
Ether Compounds for Treatment of Complement Mediated Disorders
App 20150239920 - Gadhachanda; Venkat Rao ;   et al.
2015-08-27
Amide Compounds for Treatment of Complement Mediated Disorders
App 20150239893 - Wang; Qiuping ;   et al.
2015-08-27
Compounds for Treatment of Complement Mediated Disorders
App 20150239838 - Phadke; Avinash S. ;   et al.
2015-08-27
Carbamate, Ester, and Ketone Compounds for Treatment of Complement Mediated Disorders
App 20150239919 - Gadhachanda; Venkat Rao ;   et al.
2015-08-27
8-methoxy-9H-isothiazolo[5,4-B]quinoline-3,4-diones and related compounds as anti-infective agents
Grant 8,946,422 - Bradbury , et al. February 3, 2
2015-02-03
Substituted Aliphanes, Cyclophanes, Heteraphanes, Heterophanes, Hetero-heteraphanes And Metallocenes Useful For Treating Hcv Infections
App 20140323458 - Wiles; Jason Allan ;   et al.
2014-10-30
Deuterated Nucleoside Prodrugs Useful For Treating Hcv
App 20140309164 - Deshpande; Milind ;   et al.
2014-10-16
Highly Active Nucleoside Derivative For The Treatment Of Hcv
App 20140309189 - Deshpande; Milind ;   et al.
2014-10-16
NS5A inhibitors useful for treating HCV
Grant 8,835,456 - Wiles , et al. September 16, 2
2014-09-16
Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections
Grant 8,809,313 - Wiles , et al. August 19, 2
2014-08-19
4-amino-4-oxobutanoyl Peptide Cyclic Analogues, Inhibitors Of Viral Replication
App 20140206604 - Phadke; Avinash ;   et al.
2014-07-24
New 4-amino-4-oxobutanoyl Peptides As Inhibitors Of Viral Replication
App 20140113890 - Phadke; Avinash ;   et al.
2014-04-24
4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
Grant 8,614,180 - Phadke , et al. December 24, 2
2013-12-24
Cyclic carboxamide compounds and analogues thereof as of hepatitis C virus
Grant 8,445,430 - Zhang , et al. May 21, 2
2013-05-21
Subsituted Aliphanes, Cyclophanes, Heteraphanes, Heterophanes, Hetero-heteraphanes And Metallocenes Useful For Treating Hcv Infections
App 20120302538 - Wiles; Jason Allan ;   et al.
2012-11-29
Heteroaryl substituted thiazoles
Grant 8,183,263 - Wang , et al. May 22, 2
2012-05-22
New Isothiazoloquinolones And Related Compounds As Anti-infective Agents
App 20120114601 - Bradbury; Barton James ;   et al.
2012-05-10
Hydroxylthienoquinolones and related compounds as anti-infective agents
Grant 8,173,636 - Bradbury , et al. May 8, 2
2012-05-08
Thiazole Compounds And Methods Of Use
App 20120108576 - Zhang; Suoming ;   et al.
2012-05-03
Urea-containing peptides as inhibitors of viral replication
Grant 8,163,693 - Chen , et al. April 24, 2
2012-04-24
8-methoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones And Related Compounds As Anti-infective Agents
App 20120040959 - Bradbury; Barton James ;   et al.
2012-02-16
Isothiazoloquinolones and related compounds as anti-infective agents
Grant 8,114,888 - Bradbury , et al. February 14, 2
2012-02-14
Thiazole compounds and methods of use
Grant 8,088,806 - Zhang , et al. January 3, 2
2012-01-03
8-methoxy-9H-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-infective agents
Grant 8,044,204 - Bradbury , et al. October 25, 2
2011-10-25
Isothiazoloquinolones And Related Compounds As Anti-infective Agents
App 20110223132 - Bradbury; Barton James ;   et al.
2011-09-15
Hydroxythienoquinolones And Related Compounds As Anti-infective Agents
App 20100256112 - BRADBURY; Barton James ;   et al.
2010-10-07
4-amino-4-oxobutanoyl Peptides As Inhibitors Of Viral Replication
App 20100216725 - Phadke; Avinash ;   et al.
2010-08-26
Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
Grant 7,767,706 - Phadke , et al. August 3, 2
2010-08-03
4-amino-4-oxobutanoyl Peptide Cyclic Analogues, Inhibitors Of Viral Replication
App 20100152103 - Phadke; Avinash ;   et al.
2010-06-17
Cyclic Carboxamide Compounds And Analogues Thereof As Of Hepatitis C Virus
App 20100124545 - Zhang; Suoming ;   et al.
2010-05-20
Combination Therapy For Treating Hepatitis C Infections
App 20100029652 - Huang; Mingjun ;   et al.
2010-02-04
Urea-containing Peptides As Inhibitors Of Viral Replication
App 20090082261 - Chen; Dawei ;   et al.
2009-03-26
Heteroaryl Substituted Thiazoles
App 20090041720 - Wang; Xiangzhu ;   et al.
2009-02-12
Substituted Aryl Acylthioureas And Related Compounds; Inhibitors Of Viral Replication
App 20090023730 - Phadke; Avinash ;   et al.
2009-01-22
Substituted aryl thioureas and related compounds; inhibitors of viral replication
Grant 7,476,686 - Chen , et al. January 13, 2
2009-01-13
4-substituted-1h-isothiazolo[5,4-b][1,4]oxazino[2,3,4-ij]quinoline-7,8(2h,- 9h)-diones And Related Compounds As Anti-infective Agents
App 20090012071 - Bradbury; Barton James ;   et al.
2009-01-08
Azabenzofuran substituted thioureas; inhibitors of viral replication
Grant 7,439,374 - Thurkauf , et al. October 21, 2
2008-10-21
Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
Grant 7,365,068 - Phadke , et al. April 29, 2
2008-04-29
8-N-substituted-2H-isothiazolo[5,4-b]quinolizine-3,4-diones and related compounds as antiinfective agents
Grant 7,199,128 - Bradbury , et al. April 3, 2
2007-04-03
8-methoxy-9H-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-infective agents
App 20070049586 - Bradbury; Barton James ;   et al.
2007-03-01
Iminothiazolidinones as inhibitors of HCV replication
Grant 7,183,302 - Romine , et al. February 27, 2
2007-02-27
Inhibitors of HIV-1 capsid formation: substituted aryl aminomethyl thiazole ureas and analogues thereof
Grant 7,183,300 - Summers , et al. February 27, 2
2007-02-27
Thiazole compounds and methods of use
App 20070004711 - Zhang; Suoming ;   et al.
2007-01-04
New isothiazoloquinolones and related compounds as anti-infective agents
App 20060235041 - Bradbury; Barton James ;   et al.
2006-10-19
Substituted aryl thioureas and related compounds; inhibitors of viral replication
Grant 7,094,807 - Chen , et al. August 22, 2
2006-08-22
8-N-substituted-2H-isothiazolo[5,4-b]quinolizine-3,4-diones and related compounds as antiinfective agents
App 20060173026 - Bradbury; Barton J. ;   et al.
2006-08-03
8A,9-dihydro-4aH-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-infective agents
App 20060100215 - Bradbury; Barton J. ;   et al.
2006-05-11
Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
App 20060025416 - Phadke; Avinash ;   et al.
2006-02-02
Substituted aryl thioureas and related compounds; inhibitors of viral replication
App 20060014836 - Chen; Dawei ;   et al.
2006-01-19
Azabenzofuran substituted thioureas; inhibitors of viral replication
App 20050228013 - Thurkauf, Andrew ;   et al.
2005-10-13
Iminothiazolidinones as inhibitors of HCV replication
App 20050096364 - Romine, Jeffrey Lee ;   et al.
2005-05-05
Combination pharmaceutical agents as inhibitors of HCV replication
App 20050069522 - Colonno, Richard ;   et al.
2005-03-31
Substituted aryl thioureas and related compounds; inhibitors of viral replication
App 20040138205 - Chen, Dawei ;   et al.
2004-07-15
Antiviral indoleoxoacetyl piperazine derivatives
Grant 6,469,006 - Blair , et al. October 22, 2
2002-10-22
Company Registrations
SEC0001378588Deshpande Milind

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed